Reach Us +1-217-403-9671
Biophotonics: Application Towards Modern Drug Discovery | 8391
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Biophotonics: Application towards Modern Drug Discovery

International Conference & Exhibition Bioequivalence and Bioavailability

Srinivas Kantevari

ScientificTracks Abstracts: J Bioequiv Availab

DOI: 10.4172/0975-0851.1000001

U sed in conjunction with other technologies the light beam becomes a uniquely powerful tool to study cells. We use this light source not only to observe cells, but also to stimulate cellular chemistry. This area of biophotonics is called ?caged compounds? as synthetic organic chemistry is used to make biologically signaling molecules functionally inert; irradiation liberates the caged molecules, thus ?switching on? a chosen signaling pathway. We have developed many caged compounds for stimulating both intracellular and extracellular receptors. With reference to IP3-Calcium signaling cascade, here I describe few examples of widely used caged compounds, their design features, synthesis and some extent their applicability in living cells. Fluorescent imaging probes are also playing vital role in recent years and becoming a part In the process of drug discovery and development. I also describe here on the development of imaging probes in reference to the Alzheimer Disease (AD) for diagnosis and drug development.